TrialThe Journal of dermatology2018

Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.

Shinichi Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.